Bioluminescence imaging of myeloperoxidase activity in vivo

Shimon Gross, Seth T. Gammon, Britney L. Moss, Daniel Rauch, John Harding, Jay W. Heinecke, Lee Ratner, David Piwnica-Worms

Research output: Contribution to journalArticlepeer-review

275 Scopus citations

Abstract

The myeloperoxidase (MPO) system of activated phagocytes is central to normal host defense mechanisms, and dysregulated MPO contributes to the pathogenesis of inflammatory disease states ranging from atherosclerosis to cancer. Here we show that upon systemic administration, the small molecule luminol enables noninvasive bioluminescence imaging (BLI) of MPO activity in vivo. Luminol-BLI allowed quantitative longitudinal monitoring of MPO activity in animal models of acute dermatitis, mixed allergic contact hypersensitivity, focal arthritis and spontaneous large granular lymphocytic tumors. Bioluminescence colocalized with histological sites of inflammation and was totally abolished in gene-deleted Mpo / mice, despite massive tissue infiltration of neutrophils and activated eosinophils, indicating that eosinophil peroxidase did not contribute to luminol-BLI in vivo. Thus, luminol-BLI provides a noninvasive, specific and highly sensitive optical readout of phagocyte-mediated MPO activity in vivo and may enable new diagnostic applications in a wide range of acute and chronic inflammatory conditions.

Original languageEnglish (US)
Pages (from-to)455-461
Number of pages7
JournalNature medicine
Volume15
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Bioluminescence imaging of myeloperoxidase activity in vivo'. Together they form a unique fingerprint.

Cite this